We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App





Mindray Showcases Comprehensive IVD Solutions Portfolio at MEDLAB Middle East 2020

By LabMedica International staff writers
Posted on 06 Feb 2020
Print article
Illustration
Illustration
Mindray (Shenzhen, China) showcased its range of in-vitro diagnostic products at MEDLAB 2020, including its CAL 6000 Cellular Analysis Line, SAL 9000 Modular System, CL-900i Chemiluminescence lmmunoassay System and BC-5150 Auto Hematology Analyzer.

Over 25,800 medical laboratory industry professionals and 600 exhibitors from 35 countries met in Dubai for MEDLAB Middle East, the Middle East & North Africa (MENA) region’s largest medical laboratory exhibition and congress, which took place from 3-6 February 2020 at the Dubai World Trade Centre.

At this year’s MEDLAB, Mindray showcased its CAL 6000 Cellular Analysis Line which combine two units of BC-6000 or BC-6200 auto hematology analyzers and one unit of SC-120 to deliver a throughput of up to 220 tests per hour and 120 slides per hour. The CAL 6000 is equipped with three loading platforms and three unloading platforms with large capacities. The bidirectional loading track, with patent technology, on the first hematology analyzer enables fast sample distribution, improving efficiency and productivity. Should the sample results trigger the criteria, the autoloader of each hematology analyzer will return the sample racks for automatic rerun or reflex check.

Mindray also presented its SAL 9000 Modular System which delivers high throughputs of chemistry and immunoassay testing by integrating its BS-2000 Chemistry Analyzer and CL-6000i Chemiluminescence Immunoassay Analyzer, and new Sample Processing System SPL 2000. With patented automatic serum analysis design, SAL 9000 helps optimize the management of lab space and manpower, and also offers highly reliable test results.

Additionally, Mindray showcased the CL-900i, one of the world’s smallest, fully automated chemiluminescence immunoassay analyzers, that integrates a large capacity and fast assay speed into a compact model, achieving a perfect balance between size and immunoassay testing performance. The CL-900i has a throughput of up to 180 tests/hour, and offers 50 sample positions and 15 reagent positions.

At MEDLAB Middle East, Mindray exhibited the BC-5150 Auto Hematology Analyzer which is especially tailored to assist diagnostic labs that need full CBC + 5-part results, with relatively low daily sample volume, restricted lab space and tight budget. As the lightest and most compact 5-part hematology analyzer so far from Mindray, BC-5150 is a highly user-friendly and innovative, offering cost-efficient CBC and 5-part white cell differential results.

Related Links:
Mindray

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Nutating Mixer
Enduro MiniMix
New
Calprotectin Assay
Fecal Calprotectin ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.